Furthermore, clinical cohort analysis indicated significantly increased PCLAF immunoreactivity in tumor tissues relative to normal liver tissues, and the PCLAF expression pattern was congruent across patients exhibiting high PCLAF and CLTB expressions (Figure 3N). Here, CLTB is linked to neoplasm.